LDRT and Chemoimmunotherapy in NPC With Liver Metastasis

Abroad (travel likely)RecruitingPHASE2

Conditions

Nasopharyngeal Cancinoma (NPC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Third Xiangya Hospital, Central South University,, Changsha, Hunan, China

    Contact: Study coordinator (Qingnan Tang) · qingnantang@qq.com · 8615692028619
    Contact: Principal Investigator (Xi Pan)
  • Xiangya Hospital of Central South University, Changsha, Hunan, China

    Contact: Study coordinator (Qin Zhou) · zhouqin5796@csu.edu.cn
    Contact: Principal Investigator (Qin Zhou)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Huai Liu) · liuhuai@hnca.org.cn · +8673189762230
    Contact: Principal Investigator (Huai Liu, M.D.)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Hui Wang, M.D.) · wanghui@hnca.org.cn · +8673189762230
  • The First People's Hospital of Chenzhou, Chenzhou, Hunan, China

    Contact: Study coordinator (Qiyuan Zhou) · czyyflgcp@163.com · 8618175547107
    Contact: Principal Investigator (Jinyong Tang)
  • Hunan University of Medicine General Hospital, Huaihua, Hunan, China

    Contact: Study coordinator (Hanbing Wu) · 466875142@qq.com · +8618774797921
  • The Central Hospital of Shaoyang, Shaoyang, Hunan, China

    Contact: Study coordinator (Xinfu Liu) · xinfuliudoc@163.com · 8615807397520
    Contact: Principal Investigator (Xinfu Liu)
  • Yueyang Central Hospital, Yueyang, Hunan, China

    Contact: Study coordinator (Jie Weng) · 3173720582@qq.com · 8613975070672
    Contact: Principal Investigator (Jie Weng)